Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington’s disease
Open Access
- 11 October 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 104 (3) , 846-858
Abstract
A CAG‐repeat gene expansion translated into a pathogenic polyglutamine stretch at the N‐terminus of huntingtin triggers Huntington’s Disease. Mutated huntingtin is predicted to adopt toxic properties mainly if aggregation‐prone N‐terminal fragments are released by proteolysis. Huntingtin‐aggregates are indeed a major hallmark of this disorder and could represent useful markers of disease‐onset or progression. We designed a simple method for qualitative and quantitative characterization of aggregates. For this, we analyzed samples from in vitro and in vivo Huntington’s Disease models by agarose gel electrophoresis and showed that in the brain of transgenic mice huntingtin‐aggregates became larger as a function of disease progression. This appears to be a property of cytoplasmic but not nuclear aggregates. In cell cultures, treatment with Congo Red inhibited aggregate growth but not total load. Finally, we showed that in primary striatal neurons and in brains of R6/2 and HdhQ150 mice, the presence of aggregates preceded initiation of any other functional deficits. This observation argues for a pathogenic role of huntingtin‐aggregation in Huntington’s Disease. Our results emphasize that thorough analysis of huntingtin metabolism and aggregation is now feasible, thus significantly improving the power of studies assessing therapies designed to lower huntingtin levels or to interfere with its aggregation.Keywords
This publication has 55 references indexed in Scilit:
- Congo red and protein aggregation in neurodegenerative diseasesBrain Research Reviews, 2007
- Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragmentNeurobiology of Disease, 2005
- Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's DiseaseJournal of Biological Chemistry, 2005
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicityJournal of Molecular Biology, 2001
- Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c releaseHuman Molecular Genetics, 2001
- Formic Acid Dissolves Aggregates of an N-Terminal Huntingtin Fragment Containing an Expanded Polyglutamine Tract: Applying to Quantification of Protein Components of the AggregatesBiochemical and Biophysical Research Communications, 2000
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Immortalized young adult neurons from the septal region: generation and characterizationDevelopmental Brain Research, 1990